Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Alzheimer's Medication Trials

Alzheimer's medication studies

Alzheimer's medication trials start with a conversation

Alzheimer's disease studies examine investigational medications, diagnostic tools, and care approaches, both for people with memory and thinking changes and for those who care for them. On Alzheimer's Medication Trials you see the studies now open for recruitment, and we introduce you to the team running one. You begin with a brief talk. There is no fee for it, and it obliges you to nothing.

Call (888) 927-5916
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed
An older person's hands holding a pill case
Photo by Towfiqu barbhuiya on Pexels
All locations

Alzheimer's medication studies in numbers

Alzheimer's medication studies recruiting in the U.S.
90
states with a study site
41
cities with a study site
244
studies that accept healthy volunteers
31

Source: ClinicalTrials.gov. Data processed .

Find Alzheimer's medication studies near you

These states have the most studies recruiting right now.

Alzheimer's medication studies recruiting now

As of November 17, 2026, 90 Alzheimer's medication studies are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that test a medication, as each study is coded in the registry. This is what they have in common.

What they test

  • medications90
  • other approaches11
  • behavioral approaches such as talk therapy or training2
  • diagnostic tests2
  • biologics such as vaccines or antibodies1

A study can test more than one.

Main purpose

  • treating a condition59
  • diagnosis19
  • prevention4
  • basic science3

Phase

  • Early Phase 12
  • Phase 118
  • Phase 1/28
  • Phase 235
  • Phase 2/34
  • Phase 317
  • Phase 45
  • No phase1

Studies of devices and behavioral approaches have no phase.

Who runs them

  • industry44
  • university, hospital or other42
  • government4

Who they enroll

  • adults (18 to 64)86
  • older adults (65 and over)88

31 also accept healthy volunteers.

Where: sites in 41 states. The cities with the most are Maitland, FL (16), Miami, FL (14), Tampa, FL (14), Orlando, FL (13), New York, NY (11), St Louis, MO (11), Boston, MA (10), Indianapolis, IN (10).

These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.

Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 90 studies.

Recently updated Alzheimer's medication studies

The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.

  1. A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

    • Phase 3
    • Ages 60 to 85
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Recruiting in
    Albany, NY · Amherst, NY · Buffalo, NY · and 21 more U.S. locations
    Registry record
    NCT06976203 · updated
  2. A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

    • Phase 3
    • Ages 60 to 85
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Recruiting in
    Atlantis, FL · Aventura, FL · Basalt, CO · and 21 more U.S. locations
    Registry record
    NCT06976216 · updated
  3. PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)

    • Phase 1
    • Ages 50 to 100
    • All sexes
    Sponsor
    National Institute of Mental Health (NIMH)
    Recruiting in
    Bethesda, MD
    Registry record
    NCT07169630 · updated
  4. Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin

    • Phase 2
    • Ages 65 to 120
    • All sexes
    Sponsor
    National Institute on Aging (NIA)
    Recruiting in
    Baltimore, MD
    Registry record
    NCT07721467 · updated
  5. A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease

    • Phase 1
    • Ages 18 to 85
    • All sexes
    Sponsor
    Eli Lilly and Company
    Recruiting in
    Daytona Beach, FL
    Registry record
    NCT07787182 · updated
  6. Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease

    • Phase 2
    • Ages 50 to 90
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Recruiting in
    Laurelton, NY · Stuart, FL · Wellington, FL · and 1 more U.S. location
    Registry record
    NCT07781657 · updated

Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in the United States on ClinicalTrials.gov.

Not sure which study fits?

Tell a coordinator what you are looking for. They will explain which Alzheimer's medication studies may be worth a closer look and what the next step is. Asking does not commit you to anything.

Call (888) 927-5916

What Alzheimer's disease studies look at

Research into Alzheimer's disease covers investigational medications, diagnostic tools, and care approaches. These are studied for people with memory and thinking changes and for the people who care for them. One study sets out to answer one specific question. Because of that, what you or the person you care for would be asked to do varies from one study to the next.

Whatever a study is testing is investigational. Researchers are still finding out how well it works and what risks it carries, and that is why the study is being run.

Who may be able to take part

No two Alzheimer's medication trials ask for exactly the same things. The criteria can cover your age, your health history, the medications you take now, and how Alzheimer's affects you. People who do not have Alzheimer's are also enrolled in some studies.

You are not expected to judge for yourself whether you fit. Staff on the study team assess that with you at a screening visit. Learn how screening and eligibility are handled.

How taking part works

The process has four steps. At each one, the choice to go further is yours.

  1. Tell us what you are looking for

    You call or send in a short form. Tell us the condition or the kind of study you have in mind.

  2. Talk with a coordinator

    You speak with a coordinator, who goes through the Alzheimer's studies that might suit your situation. Ask whatever you like. The answers come in everyday words.

  3. Meet the study team

    The study team takes over if you choose to go on. They go through the study with you in detail and check whether you are eligible.

  4. Decide what is right for you

    Participation is your choice at every point. You may change your mind and leave a study whenever you wish, whatever your reason.

Why people take part in Alzheimer's medication studies

People have different reasons for joining an Alzheimer's study. Each one is worth talking through before you decide.

  • A research team would follow their health closely while the study runs.
  • They want to understand more about a condition they live with.
  • They want to help researchers answer questions that may shape care for other people later on.

A study is research. It is not treatment, and nobody can promise that taking part will help you personally. For a plain explanation, read what a clinical trial is.

Your safety and your rights come first

No Alzheimer's medication trial can enroll a single person until an independent ethics committee has reviewed it. You also receive the study details as a written document, and only after that are you asked to agree to anything. These pages explain informed consent, the way each study is reviewed and monitored, and the rights that stay with you the whole time you take part.

Common questions about Alzheimer's medication studies

Do I need a diagnosis to join a study about Alzheimer's disease?

There is no single answer, because each Alzheimer's study sets this for itself. In some, a diagnosis must already be confirmed. In others, the assessment is done as part of screening. Which of the two holds for a given study is something its team will explain to you.

Would I have to change the care I receive now?

Whether your current care can continue depends on the individual Alzheimer's medication trial. It carries on unchanged in some trials and cannot in others. Leave your care exactly as it is and make no changes by yourself. The study doctor goes through this question with you, and you can discuss it with your own doctor before you decide.

Is there a cost to take part?

As a rule, the study medication, the study's tests, and the study visits come at no charge to you as a participant. Our page on costs has more detail.

Does it cost anything to ask about a study?

No. A conversation with Alzheimer's Medication Trials costs you nothing. Asking questions does not enroll you in anything.

Do I have to take part if I call?

No. Whether to go on is your decision at each step, and stopping is possible at any time.

Who decides whether I can join a study?

That decision rests with the study team, and they make it following your screening visit. The criteria differ from one Alzheimer's study to the next. Read about the screening process.

Ask about Alzheimer's medication studies

It takes only a few details from you for a coordinator to get in touch. Enquiring about an Alzheimer's study leaves you free of any commitment.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Learn more from independent sources

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5916

or send a short form

How should we reach you?

Call